For cancer clinical studies, increased patient numbers will improve confidence in demarcating specific roles for OIP5‐AS1 in each tumour type, especially given the capacity to function as an oncogene or tumour suppressor depending on the context (Table 2). The gene discussed is OIP5; the disease is neoplasm.